InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Browse the full record of transactions filed by Hamdy Ahmed MD, 董事长兼首席执行官. Insider active across 2 companies, notably Vincerx Pharma, Inc.. In total, 6 filings have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €133k. History available since 22 December 2021. The latest transaction was filed on 9 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Hamdy Ahmed MD is the Chief Executive Officer of Vincerx Pharma, Inc. In this role, he is responsible for the strategic direction and operations of the company. His experience in the pharmaceutical sector enables him to lead innovative initiatives and foster Vincerx's growth. He plays a key role in developing new therapeutic solutions.